A COMPARISON OF THE VALUE-RELEVANCE OF UNITED-STATES VERSUS NON-UNITED-STATES GAAP ACCOUNTING MEASURES USING FORM-20-F RECONCILIATIONS - DISCUSSION

被引:5
|
作者
POPE, PF
机构
关键词
D O I
10.2307/2491173
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
引用
收藏
页码:265 / 275
页数:11
相关论文
共 7 条
  • [1] A COMPARISON OF THE VALUE-RELEVANCE OF UNITED-STATES VERSUS NON-UNITED-STATES GAAP ACCOUNTING MEASURES USING FORM-20-F RECONCILIATIONS
    AMIR, E
    HARRIS, TS
    VENUTI, EK
    JOURNAL OF ACCOUNTING RESEARCH, 1993, 31 : 230 - 264
  • [2] COMPARISON OF CLINICAL OUTCOMES IN THE UNITED-STATES AND NON-UNITED-STATES COUNTRIES PARTICIPATING IN GUSTO
    VANDEWERF, F
    BARBASH, G
    ARMSTRONG, P
    SIMES, J
    GRANGER, C
    CIRCULATION, 1993, 88 (04) : 507 - 507
  • [3] The market valuation of IAS versus US-GAAP accounting measures using Form 20-F reconciliations
    Harris, MS
    Muller, KA
    JOURNAL OF ACCOUNTING & ECONOMICS, 1999, 26 (1-3): : 285 - 312
  • [4] CROSS-CULTURAL-COMPARISON OF UNITED-STATES AND NON-UNITED-STATES CONSUMER COMPLAINT BEHAVIOR AND RETAILER RESPONSE
    STEM, DE
    ASUGMAN, G
    HATTRUP, M
    VAIDYANATHAN, R
    PROCEEDINGS OF THE FIFTH BI-ANNUAL INTERNATIONAL CONFERENCE OF THE ACADEMY OF MARKETING SCIENCE, 1991, 5 : 280 - 285
  • [5] A COMPARISON OF REGIONAL DROUGHT PATTERNS IN THE CONTIGUOUS UNITED-STATES USING 4 MEASURES OF DROUGHT SEVERITY
    SOULE, PT
    MEENTEMEYER, V
    SIXTH CONFERENCE ON APPLIED CLIMATOLOGY, 1989, : 84 - 87
  • [6] An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
    Christos Chouaid
    Lise Bosquet
    Nicolas Girard
    Anna Kron
    Matthias Scheffler
    Frank Griesinger
    Martin Sebastian
    Jose Trigo
    Santiago Viteri
    Craig Knott
    Bernardo Rodrigues
    Nora Rahhali
    Jedelyn Cabrieto
    Joris Diels
    Nolen J. Perualila
    Claudio A. Schioppa
    Jan Sermon
    Raphael Toueg
    Nicole Erdmann
    Janka Mielke
    Mehregan Nematian-Samani
    Cristina Martin-Fernandez
    Innocent Pfaira
    Tracy Li
    Parthiv Mahadevia
    Jürgen Wolf
    Advances in Therapy, 2023, 40 : 1187 - 1203
  • [7] An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
    Chouaid, Christos
    Bosquet, Lise
    Girard, Nicolas
    Kron, Anna
    Scheffler, Matthias
    Griesinger, Frank
    Sebastian, Martin
    Trigo, Jose
    Viteri, Santiago
    Knott, Craig
    Rodrigues, Bernardo
    Rahhali, Nora
    Cabrieto, Jedelyn
    Diels, Joris
    Perualila, Nolen J.
    Schioppa, Claudio A.
    Sermon, Jan
    Toueg, Raphael
    Erdmann, Nicole
    Mielke, Janka
    Nematian-Samani, Mehregan
    Martin-Fernandez, Cristina
    Pfaira, Innocent
    Li, Tracy
    Mahadevia, Parthiv
    Wolf, Juergen
    ADVANCES IN THERAPY, 2023, 40 (03) : 1187 - 1203